DNTH Earnings

Quarterly EPS
$-0.74
Q3 2024
$-0.73
Q4 2024
$-0.82
Q1 2025
$-0.88
Q2 2025
$-0.97
Q3 2025
$-1.43
Q4 2025
$-0.85
Q1 2026
$-0.90
Q2 2026
Latest Revenue761.0K
Latest Net Income-50215000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.90761.0K-50215000+294.3%-2.3%
Q1 2026-$0.85463.0K-40834000-60.2%-3.7%
Q4 2025-$1.43284.0K-64432000-78.6%-95.9%
Q3 2025-$0.97396.0K-36765000-81.8%-31.1%
Q2 2025-$0.88193.0K-31629000-89.6%-72.5%
Q1 2025-$0.821.2M-29511000+33.1%-51.9%
Q4 2024-$0.731.3M-28440000+190.2%-2.8%
Q3 2024-$0.742.2M-25174000+135.1%+80.4%
Q2 2024-$0.511.9M-17607000
Q1 2024-$0.54874.0K-13748000
Q4 2023-$0.71457.0K-10563000
Q3 2023-$3.78924.0K-14763000
Dianthus Therapeutics (DNTH) — Earnings